Affiliation:
1. Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA
2. Nutrition College of Agriculture Texas A&M University College Station TX 77843 USA
3. Material Science and Engineering College of Engineering Texas A&M University College Station TX 77843 USA
4. Medical Physiology School of Medicine Texas A&M Health Science Center Bryan TX USA
5. Cardiovascular Sciences Houston Methodist Research Institute Houston TX 77030 USA
6. Interdisciplinary Graduate Program in Genetics & Genomics Texas A&M University College Station TX 77843 USA
7. Center for Remote Health Technologies and Systems Texas A&M University College Station TX 77843 USA
Abstract
AbstractGranular hydrogels composed of hydrogel microparticles are promising candidates for 3D bioprinting due to their ability to protect encapsulated cells. However, to achieve high print fidelity, hydrogel microparticles need to jam to exhibit shear‐thinning characteristics, which is crucial for 3D printing. Unfortunately, this overpacking can significantly impact cell viability, thereby negating the primary advantage of using hydrogel microparticles to shield cells from shear forces. To overcome this challenge, a novel solution: a biphasic, granular colloidal bioink designed to optimize cell viability and printing fidelity is introduced. The biphasic ink consists of cell‐laden polyethylene glycol (PEG) hydrogel microparticles embedded in a continuous gelatin methacryloyl (GelMA)‐nanosilicate colloidal network. Here, it is demonstrated that this biphasic bioink offers outstanding rheological properties, print fidelity, and structural stability. Furthermore, its utility for engineering complex tissues with multiple cell types and heterogeneous microenvironments is demonstrated, by incorporating β‐islet cells into the PEG microparticles and endothelial cells in the GelMA‐nanosilicate colloidal network. Using this approach, it is possible to induce cell patterning, enhance vascularization, and direct cellular function. The proposed biphasic bioink holds significant potential for numerous emerging biomedical applications, including tissue engineering and disease modeling.
Funder
National Institute of Dental and Craniofacial Research
National Institute of Biomedical Imaging and Bioengineering
National Science Foundation
American Heart Association
Biomedical Advanced Research and Development Authority
U.S. Food and Drug Administration
National Institutes of Health
Texas A and M University
National Aeronautics and Space Administration